16.10.2014
- Bayer soon may find itself regretting its decision to sell its plastics business and become a pure life science player. According to international press reports, the German group's...
02.06.2014
- German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...
20.02.2014
- German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...
